995 related articles for article (PubMed ID: 21802134)
1. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
Nelson PK; Mathers BM; Cowie B; Hagan H; Des Jarlais D; Horyniak D; Degenhardt L
Lancet; 2011 Aug; 378(9791):571-83. PubMed ID: 21802134
[TBL] [Abstract][Full Text] [Related]
2. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review.
Degenhardt L; Peacock A; Colledge S; Leung J; Grebely J; Vickerman P; Stone J; Cunningham EB; Trickey A; Dumchev K; Lynskey M; Griffiths P; Mattick RP; Hickman M; Larney S
Lancet Glob Health; 2017 Dec; 5(12):e1192-e1207. PubMed ID: 29074409
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: a systematic review.
Degenhardt L; Webb P; Colledge-Frisby S; Ireland J; Wheeler A; Ottaviano S; Willing A; Kairouz A; Cunningham EB; Hajarizadeh B; Leung J; Tran LT; Price O; Peacock A; Vickerman P; Farrell M; Dore GJ; Hickman M; Grebely J
Lancet Glob Health; 2023 May; 11(5):e659-e672. PubMed ID: 36996857
[TBL] [Abstract][Full Text] [Related]
4. Global estimates of prevalence of HCV infection among injecting drug users.
Aceijas C; Rhodes T
Int J Drug Policy; 2007 Oct; 18(5):352-8. PubMed ID: 17854722
[TBL] [Abstract][Full Text] [Related]
5. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
6. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage.
Mathers BM; Degenhardt L; Ali H; Wiessing L; Hickman M; Mattick RP; Myers B; Ambekar A; Strathdee SA;
Lancet; 2010 Mar; 375(9719):1014-28. PubMed ID: 20189638
[TBL] [Abstract][Full Text] [Related]
7. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
8. Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
Degenhardt L; Charlson F; Stanaway J; Larney S; Alexander LT; Hickman M; Cowie B; Hall WD; Strang J; Whiteford H; Vos T
Lancet Infect Dis; 2016 Dec; 16(12):1385-1398. PubMed ID: 27665254
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
10. Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.
Hahné SJ; Veldhuijzen IK; Wiessing L; Lim TA; Salminen M; Laar Mv
BMC Infect Dis; 2013 Apr; 13():181. PubMed ID: 23597411
[TBL] [Abstract][Full Text] [Related]
11. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of Hepatitis B and C among Drug-Abusing Male Prisoners in Birjand, South Khorasan, Iran.
Ghafari S; Sharifzadeh G; Jamali S; Taji B; Javadmoosavi SY; Ziaee M
Arch Iran Med; 2019 Sep; 22(9):501-504. PubMed ID: 31679371
[TBL] [Abstract][Full Text] [Related]
14. Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan.
Hsieh MH; Hsieh MY; Huang CF; Yeh ML; Wang SC; Yang JF; Chang K; Lin WR; Lin CY; Chen TC; Huang JF; Dai CY; Tsai JJ; Chuang WL; Yu ML
Kaohsiung J Med Sci; 2016 Feb; 32(2):96-102. PubMed ID: 26944329
[TBL] [Abstract][Full Text] [Related]
15. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
17. Global, regional, and country-level coverage of testing and treatment for HIV and hepatitis C infection among people who inject drugs: a systematic review.
Hajarizadeh B; Kairouz A; Ottaviano S; Ireland J; Willing A; Cunningham E; Webb P; Colledge-Frisby S; Wheeler A; Leung J; Tran LT; Price O; Vickerman P; Farrell M; Hickman M; Dore GJ; Bergenström A; Degenhardt L; Grebely J
Lancet Glob Health; 2023 Dec; 11(12):e1885-e1898. PubMed ID: 37973339
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil.
Oliveira ML; Bastos FI; Telles PR; Yoshida CF; Schatzmayr HG; Paetzold U; Pauli G; Schreier E
Braz J Med Biol Res; 1999 Sep; 32(9):1107-14. PubMed ID: 10464387
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of HIV, HCV, HBV and co-infection and associated risk factors among injecting drug users in Yunnan province, China.
Zhou YH; Yao ZH; Liu FL; Li H; Jiang L; Zhu JW; Zheng YT
PLoS One; 2012; 7(8):e42937. PubMed ID: 22916185
[TBL] [Abstract][Full Text] [Related]
20. Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.
Shapatava E; Nelson KE; Tsertsvadze T; del Rio C
Drug Alcohol Depend; 2006 Apr; 82 Suppl 1():S35-8. PubMed ID: 16769443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
